D
Dae Jung Kim
Researcher at Ajou University
Publications - 379
Citations - 10811
Dae Jung Kim is an academic researcher from Ajou University. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 45, co-authored 336 publications receiving 8366 citations. Previous affiliations of Dae Jung Kim include Yonsei University & Texas A&M University.
Papers
More filters
Journal ArticleDOI
Appropriate waist circumference cutoff points for central obesity in Korean adults
Sang Yeoup Lee,Hye Soon Park,Dae Jung Kim,Jee Hye Han,Seon Mee Kim,Guem Joo Cho,Dae Young Kim,Hyuk-Sang Kwon,Sung Rae Kim,Chang Beom Lee,Seung Joon Oh,Cheol-Young Park,Hyung Joon Yoo +12 more
TL;DR: The findings suggest the applicability of ethnically specific cutoff points for WC in assessing central obesity in Koreans to predict increased risk of elevated triacylglycerol, reduced HDL cholesterol, elevated blood pressure, elevated fasting plasma glucose, or two or more of these factors.
Journal ArticleDOI
Differential Significance of Plasma Visfatin Concentrations according to Adiposity in Children and Adolescents
TL;DR: It is suggested that the relationship between plasma visfatin concentrations and metabolic parameters differs according to central adiposity and that plasma visFatin concentrations are correlated with visceral fat and triglyceride levels, especially in children and adolescents with lower adiposity.
Journal ArticleDOI
Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese, Nondiabetic Adults
Hae Jin Kim,Hyeong Jin Kim,Kwang Eun Lee,Dae Jung Kim,Dae Jung Kim,Soo Kyung Kim,Chul Woo Ahn,Sung Kil Lim,Kyung Rae Kim,Hyun Chul Lee,Kap Bum Huh,Bong Soo Cha +11 more
TL;DR: Nonalcoholic fatty liver disease is closely associated with metabolic disorders, even in nonobese, nondiabetic subjects, and can be considered an early predictor of metabolic Disorders, particularly in the normal-weight population.
Journal ArticleDOI
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study
Mikhail Kosiborod,Carolyn S.P. Lam,Shun Kohsaka,Dae Jung Kim,Dae Jung Kim,Avraham Karasik,Jonathan E. Shaw,Navdeep Tangri,Su-Yen Goh,Marcus Thuresson,Hungta Chen,Filip Surmont,Niklas Hammar,Niklas Hammar,Peter Fenici +14 more
TL;DR: In this article, a randomized trial demonstrated a lower risk of cardiovascular events with SGLT-2 inhibitors in patients with type 2 diabetes (T2D) at high risk of adverse events.
Journal ArticleDOI
Magnesium Intake in Relation to Systemic Inflammation, Insulin Resistance, and the Incidence of Diabetes
Dae Jung Kim,Pengcheng Xun,Kiang Liu,Catherine M. Loria,Kuninobu Yokota,David R. Jacobs,David R. Jacobs,Ka He +7 more
TL;DR: Magnesium intake was inversely longitudinally associated with incidence of diabetes in young American adults, and this inverse association may be explained by the inverse correlations of magnesium intake with systemic inflammation and insulin resistance.